期刊文献+

M2型巨噬细胞在子宫内膜异位症中的表达及其与MVD的关系 被引量:2

Expression of M2-polarized macrophages in endometriosis and its relationship with MVD
原文传递
导出
摘要 目的:检测子宫内膜异位症(Endometriosis,EMs)组织中CD68、CD163的阳性表达并分析其与微血管生成的关系,探讨M2型巨噬细胞在EMs发病机制中的作用。方法:用CD68标记巨噬细胞(CD68+),用CD163标记M2型巨噬细胞(CD163+)和CD34标记微血管密度(microvessel density,MVD)。采用免疫组织化学Envision二步法检测EMs组35例异位内膜和20例EMs在位内膜以及20例正常对照组子宫内膜组织中的CD68、CD163的表达及MVD值。结果:EMs组的异位内膜及在位内膜组织中CD68、CD163、MVD的表达强度显著高于对照组(P<0.01);盆腔EMs I-II期与III-IV期比较无显著差异(P>0.05);各组月经周期中分泌期与增生期表达无显著差异(P>0.05)。EMs组异位内膜MVD与CD68+、CD163+巨噬细胞呈正相关(r=0.754,P<0.01;r=0.808,P<0.01)。结论:M2型巨噬细胞具有促血管生成作用,从而参与EMs的发生发展,阻断局部微环境中巨噬细胞向M2型分化,有望成为EMs治疗的新途径。 Objective: To detect the positive expressions of CD68 and CD163 in endometriosis, analyze their relationships with microvessel density ( MVD), explore the effect of M2 - polarized macrophages in pathogenesis of endometriosis. Methods: CD68 was used to mark macrophages, CD163 was used to mark M2 -polarized macrophages, and CD34 was used to mark MVD. Immunohistochemical method (Envision) was used to detect the expression levels of CD68 and CD163, MVD values in 35 specimens of ectopic endometrium in endometri-osis group, 20 specimens of eutopic endometrium in endometriosis group, and 20 specimens of normal endometrium in controlgroup. Results: The expression levels of CD68 and CD163, MVD values in ectopic endometrimn and eutopic endometrium in endometriosis group were significantly higher than those in control group (P 〈 0. 01 ) ; there was significant difference between pelvic endometriotic lesions of stage Ⅰ - Ⅱ and pelvic endometriotic lesions of stage Ⅲ- Ⅳ ( P 〉 0.05 ) ; in the three groups, there was no significant difference in the expression levels of CD68 and CD163, MVD values between secretory phase and proliferative phase (P 〉 0.05) . In ectopic endometrium of endometriosis group, there was a positive correlation between MVD and CD68 + macrophages and CD163 + macrophages (T = 0. 754, P 〈 0. 01 ; T = 0. 808, P 〈 0. 01 ) . Conclusion: M2 - polarized macrophages can promote angiogenesis, participate in the occurrence and development of endometriosis, block the differentiation of macrophages to M2 - polarized maerophages in local microenvironment, which is expected to be one of the new ways for treatment of endometriosis.
出处 《中国妇幼保健》 CAS 北大核心 2012年第16期2515-2519,共5页 Maternal and Child Health Care of China
关键词 M2型巨噬细胞 子宫内膜异位症 微血管密度 CD163 免疫组化 M2 - polarized macrophage Endometriosis Microvessel density CD163 Immunohistochemistry
  • 相关文献

参考文献17

  • 1曹泽毅.中华妇产科学[M].北京:人民卫生出版社,2004.2170-2172.
  • 2Weidner N. Current pathologic methods for measuring intratu- moral microvessel density within breast carcinoma and other solid tumors [J]. Breast Cancer Res Treat, 1995,36 (2) : 169.
  • 3Mosser D M. The many faces of macrophage activation [J]. J Leukoc Biol, 2003, 73 (2) : 209.
  • 4Bouhlel MA, Derudas B, Rigamonti E et al. PPAR gamma activation primes human monocytes into alternative M2 macrophages with anti -inflammatory properties [J]. Cell Metab, 2007, 6 (2): 137.
  • 5Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis [J]. Cell, 2010, 141 (1) : 39.
  • 6Wilson HM, Barker RN, Erwig LP. Macrophage : promissing targets for the treatment of atherosclerosis [J].. Curr Vasc Pharmacol, 2009, 7 (2): 234.
  • 7Haber E, Danenberg HD, Koroukhov N et al. Peritoneal macrophage depletion by liposomal bisphosphonate attenuates endometriosis in the rat model[J]. Hum Reprod,2009, 24:398.
  • 8Bacci M, Capobianco A, Monno A et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease [J]. Am J Pathol, 2009, 175 (2) : 547.
  • 9郎景和.子宫内膜异位症的研究与设想[J].中华妇产科杂志,2003,38(8):478-480. 被引量:529
  • 10Kimura H, Nakajima T, Kagawa K et al. Angiogenesis in hepatocellular carcinoma as evaluated by CD34 immunohistochemistry [J]. Liver, 1998, 18 (1): 14.

二级参考文献9

  • 1申洪.免疫组织化学染色定量方法研究(Ⅲ)[J].中国组织化学与细胞化学杂志,1995,4(1):89-92. 被引量:398
  • 2Rosenstein J M, Mani N , Silverman W F, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo[J].Proc Natl Acad Sci U S A, 1998 , 95(12): 7086-91.
  • 3Tan X J, Lang J H, Liu D Y, et al. Expression of vascular endothelial growth factor and thrombospondin-1mRNA in patients with endometriosis[J]. Fertil Steril,2002, 78 (1): 148-53.
  • 4Shifren J L, Tseng J F, Zaloudek C J, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis[J]. J Clin Endocrinol Metab, 1996 , 81(8):3112-8.
  • 5Donnez J, Smoes P, Gillerot S, et al. Vascular endothelial growth factor (VEGF) in endometriosis [J]. Hum Reprod, 1998, 13(6): 1686-90.
  • 6Khan K N, Masuzaki H, Fujishita A, et al. Immunoexpression of hepatocyte growth factor and c-Met receptor in the eutopic endometrium predicts the activity of ectopic endometrium [J]. Fertil Steril, 2003 , 79 (1): 173-81.
  • 7Sharkey A M, Day K, McPherson A, et al. Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia [J]. J Clin Endocrinol Metab,2000, 85 (1): 402-9.
  • 8Kressin P, Wolber E M, Wodrich H, et al. Vascular endothelial growth factor mRNA in eutopic and ectopic endometrium [J]. Fertil Steril, 2001 ,76(6): 1220-4.
  • 9Hull M L, Charnock-Jones D S, Chan C L, et al. Antiangiogenic agents are effective inhibitors of endometriosis[J]. J Clin Endocrinol Metab, 2003 , 88(6): 2889-99.

共引文献1316

同被引文献33

  • 1Sampson J.Peritoneal endometriosis is due to the menstrual dissemination of endometrial tissue into the peritoneal cavity.Am J Obstet Gynecol,1921,14(1):422-469.
  • 2Anger DL,Foster WG.The link between environmental toxicant exposure and endometriosis.Front Biosci,2008,13(4): 1578-1593.
  • 3Asante A,Taylor R.Endometriosis:the role of neuronangiogenesis. Annual Review of Physiology,2011,73(3):163-182.
  • 4Mosser DM.The many faces of macrophage activation.J Leukoc Biol,2003,73(2):209.
  • 5Frank AW,Tjitske DB,Dennis Langenberg ML,et al.Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco) bacteria.Proc Natl Acad Sci USA,2004,101(13):4560.
  • 6Daley JM,Brancato SK,Thomay AA,et al.The phenotype of murine wound macrophages.J Leukoc Biol, 2010,87(1):59-67.
  • 7Brancato S,Albina J.Wound macrophages as key regulators of repair:origin,phenotype,and function.Am J Pathol,2011,178(1):19.
  • 8Lyamina SV, Kruglov SV, Vednikin TY, et al. Alternative reprogramming of M1/M2 phenotype of mouse peritoneetal macrophages in vitro with interferon- γ and interleukin-4. Cell Technologies in Biology and Medicine,2012,4:235-239.
  • 9Gordon S, Martinez FO. Alternative activation of macrophages :mechanism and function.Immunity,2010,32(5):593-604.
  • 10田媛,刘起会.闫冬梅.巨噬细胞活化信号通路及其调控机制的研究进展.第九届全国免疫学学术大会,2014.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部